Hammad Ali

Dr. Hammad Ali is an Adjunct Associate Professor affiliated with the School of Public Health at the University of Queensland and the US Centers for Disease Control and Prevention (CDC). His primary research focuses on chronic kidney disease (CKD), plant-based therapies, and the molecular mechanisms of anti-inflammatory and antioxidant compounds. He investigates how natural products and phytochemicals can mitigate renal damage and oxidative stress in kidney cells, particularly through pathways like ferroptosis and apoptosis.

Dr. Ali’s work integrates cell culture models with preclinical studies to explore therapeutic interventions for CKD, emphasizing the therapeutic potential of plants such as Tabebuia pallida, Morus alba, and Mikania micrantha. His research also examines drug interactions, such as the effects of abietic acid and piperine on anti-inflammatory agents like celecoxib, revealing critical mechanistic insights.

Key themes in his publications include the development of in vitro kidney models to test plant-derived therapies, the role of oxidative stress in renal dysfunction, and the exploration of ethnopharmacological resources for treating inflammatory and kidney-related disorders. His work bridges traditional medicine and modern pharmacology, with implications for drug discovery and precision medicine in nephrology.